Top 10 New Entrants companies in PCSK9 Inhibitors by Most Patent Filing In 5 Years in the world in 2018 – Discovery

Free Trial

The PCSK9 Inhibitors top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Patent Filing In 5 Years PCSK9 Inhibitors New Entrants in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2018, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Ranking Year:

Region:

Ranking:

1	CymaBay Therapeutics, Inc.	California, United States	Drug,Gout,Drug development, ...[+2]	Patent: 15
2	F. Hoffmann-La Roche Ltd.	Switzerland	Medicine,Health care,Drug, ...[+2]	Patent: 11
3	Amgen, Inc.	California, United States	Health care,Biopharmaceutical,TUMOR NECROSIS FACTOR BLOCKER, ...[+2]	Patent: 10
4	Novo Nordisk A/S	Hovedstaden, Denmark	Insulin,Health care,Haemophilia, ...[+2]	Patent: 10
5	Institut de Cardiologie De Montreal	Canada		Patent: 4
6	Shenzhen Salubris Pharmaceuticals Co., Ltd.	Guangdong Sheng, China	Medicine,Cefaclor,Antithrombotic, ...[+2]	Patent: 3
7	Pokka Corp.	Aichi, Japan	Food industry,Soft drink,Fountain, ...[+1]	Patent: 2
8	Sanofi Biotechnology SAS	IF, FR	Biotechnology	Patent: 2
9	Tuj	United States	Transport engineering	Patent: 2
10	Fourth Military Medical University	Hunan Sheng, China	National security,BCG vaccine,HIV vaccine, ...[+2]	Patent: 1